A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD

Clinical trial NCT06847542 · RECRUITING

Trial details

NCT number: NCT06847542
Sponsor: Hoffmann-La Roche
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Neovascular Age-related Macular Degeneration

Start date: 2025-11-27
Primary completion: 2028-11-15
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.